Skip to main content
Livermore
Livermore
ZHEN

Group One Trading, L.P.

SEC CIK
0000932540
Latest filing
Aug 13, 2026

CHRS holding history

Coherus Oncology, Inc. in every 13F filed by Group One Trading, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CHRS overviewAll 13F holders of CHRSFull Q2 2026 holdings

Shares (Q2 2026)
20,846
Value
$29.2K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of CHRS by Group One Trading, L.P., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202620,846$29.2K<0.1%−90,945−81.4%ReducedHolders
Q1 2026111,791$188.9K<0.1%+70,566+171.2%AddedHolders
Q4 202541,225$58.5K<0.1%−13,986−25.3%ReducedHolders
Q3 202555,211$90.5K<0.1%−35,220−38.9%ReducedHolders
Q2 202590,431$66.1K<0.1%−34,484−27.6%ReducedHolders
Q1 2025124,915$100.8K<0.1%+124,915NewHolders
Q4 20240$00.0%−128,359−100.0%Sold outHolders
Q3 2024128,359$133.5K<0.1%−23,550−15.5%ReducedHolders
Q2 2024151,909$262.8K<0.1%−65,732−30.2%ReducedHolders
Q1 2024217,641$520.2K<0.1%−123,816−36.3%ReducedHolders
Q4 2023341,457$1.14M<0.1%+341,457NewHolders
Q3 20230$00.0%−76,535−100.0%Sold outHolders
Q2 202376,535$326.8K<0.1%+69,709+1,021.2%AddedHolders
Q1 20236,826$46.7K<0.1%−11,462−62.7%ReducedHolders
Q4 202218,288$144.8K<0.1%−5,600−23.4%ReducedHolders
Q3 202223,888$230.0K<0.1%+22,380+1,484.1%AddedHolders
Q2 20221,508$11.0K<0.1%−351−18.9%ReducedHolders
Q1 20221,859$24.0K<0.1%−9,315−83.4%ReducedHolders
Q4 202111,174$178.0K<0.1%+9,367+518.4%AddedHolders
Q3 20211,807$29.0K<0.1%−483−21.1%ReducedHolders
Q2 20212,290$32.0K<0.1%−304−11.7%ReducedHolders
Q1 20212,594$38.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.